Latest filing published 16 Jun 2025 for Sangamo Therapeutics, INC. Read the official filing
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Robert Carey has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Beyond Air, Inc. and Sangamo Therapeutics, Inc. The record holds 27 filings, for trades running from 17 June 2021 to 12 June 2025.
Every open-market trade on record is a purchase: 22 purchases worth €7.3M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants. So far in 2025, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €108k. Clusters matter here: 10 out of 22 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 16 June 2025: a share grant, in Sangamo Therapeutics, Inc. The latest purchase dates back some time: it was published 580 days ago, on 17 March 2025. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations